ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 77 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $51 | -27.1% | 1,298 | -64.9% | 0.00% | -100.0% |
| Q4 2023 | $70 | +66.7% | 3,697 | +1.1% | 0.00% | – |
| Q3 2023 | $42 | +10.5% | 3,656 | 0.0% | 0.00% | – |
| Q2 2023 | $38 | +72.7% | 3,656 | +29.1% | 0.00% | – |
| Q1 2023 | $22 | +22.2% | 2,833 | +18.8% | 0.00% | – |
| Q4 2022 | $18 | -99.9% | 2,385 | +17.5% | 0.00% | – |
| Q3 2022 | $15,000 | -11.8% | 2,030 | +0.8% | 0.00% | – |
| Q2 2022 | $17,000 | 0.0% | 2,014 | +6.5% | 0.00% | – |
| Q1 2022 | $17,000 | – | 1,891 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|